
Secondcell Bio is a biotechnology company leveraging its proprietary Chromovert® Technology, originating from The Rockefeller University, to revolutionize drug discovery and cell engineering. This platform technology enables the rapid detection and isolation of optimally engineered cells, even rare ones, by scanning millions of cells. Chromovert® bridges the gap between in silico AI designs and wet-lab validation, offering a significant competitive edge by creating cell models that accurately mimic human biology for reliable drug discovery results. The technology has diverse applications across biotechnology, including personalized medicine, biologics and vaccine manufacturing, cell and stem cell therapies, as well as environmental and consumer product sectors like sustainable farming and fragrance development. The company's founder, Dr. Kambiz Shekdar, has over 20 years of experience pursuing applications of this platform, with a vision to establish a biotechnology hub in the UAE.

Secondcell Bio is a biotechnology company leveraging its proprietary Chromovert® Technology, originating from The Rockefeller University, to revolutionize drug discovery and cell engineering. This platform technology enables the rapid detection and isolation of optimally engineered cells, even rare ones, by scanning millions of cells. Chromovert® bridges the gap between in silico AI designs and wet-lab validation, offering a significant competitive edge by creating cell models that accurately mimic human biology for reliable drug discovery results. The technology has diverse applications across biotechnology, including personalized medicine, biologics and vaccine manufacturing, cell and stem cell therapies, as well as environmental and consumer product sectors like sustainable farming and fragrance development. The company's founder, Dr. Kambiz Shekdar, has over 20 years of experience pursuing applications of this platform, with a vision to establish a biotechnology hub in the UAE.